News

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Discover the benefits of GLP-1 medications for weight loss and how they can be used in conjunction with outdoor activities in ...
Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.
GLP-1 drugs are making waves in the world of weight loss and health management, but what exactly are they? Allison Debussy, an APRN with Baptist Health Weight L ...
Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding.
From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with type 1 diabetes, and glucagon-like peptide 1 receptor agonist (GLP-1 RA) prescriptions also ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...
A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...
UK: A systematic review and meta-analysis of randomized trials have highlighted the significant benefits of long-acting ...
As demand soared for weight-loss drugs, price signals worked.